Skip to main content

Table 1 Age at diagnosis, tumor characteristics and treatment given in the TNP and non-TNP groups.

From: Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Clinical Feature No. of cases Non-TNP No. of cases TNP Odds Ratio [95% CI] P-value*
Center VGH 228 36   
  JGH 165 27 1.04 [0.61; 1.77] 0.89
Age at diagnosis 25–49 years 116 32   
  50–95 years 277 31 0.41 [0.24; 0.70] 0.001
Histological grade Grade 1 120 4   
  Grade 2 193 15 2.33 [0.76; 7.19] 0.15
  Grade 3 68 40 17.65 [6.05; 51.45] <0.0001
  Missing 12 4   
Tumor size 0–2 cm 161 18   
  2.01–15 cm 217 45 1.85 [1.04; 3.32] 0.04
  Missing 15 0   
Lymph node status Negative 205 41   
  Positive 149 13 0.44 [0.23; 0.84] 0.01
  Missing 39 9   
Hormonal Treatment None 219 49   
  Yes 161 11 0.31 [0.15; 0.61] 0.0003
  Missing 13 3   
Chemotherapy None 279 35   
  Yes 108 26 1.92 [1.10; 3.34) 0.02
  Missing 6 2   
  1. * P-values based on Fisher's exact test.